Back
DaVita, Inc. 10K Form
Buy
51
DVA
DaVita, Inc.
Last Price:
$114.68
Seasonality Move:
1.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | DVA/DaVita, Inc. Quarterly |
| 2024-02-14 | 10K | DVA/DaVita, Inc. Annual |
| 2023-11-07 | 10Q | DVA/DaVita, Inc. Quarterly |
| 2023-08-03 | 10Q | DVA/DaVita, Inc. Quarterly |
| 2023-05-08 | 10Q | DVA/DaVita, Inc. Quarterly |
| 2023-02-22 | 10K | DVA/DaVita, Inc. Annual |
Receive DVA News And Ratings
See the #1 stock for the next 7 days that we like better than DVA
DVA Financial Statistics
Sales & Book Value
| Annual Sales: | $12.8B |
|---|---|
| Cash Flow: | $675.5M |
| Price / Cash Flow: | 7.01 |
| Annual Sales: | $-8.06 |
| Price / Book: | 95.39 |
Profitability
| EPS (TTM): | 9.71170 |
|---|---|
| Net Income (TTM): | $1.1B |
| Gross Margin: | $3.5B |
| Return on Equity: | 61.87% |
| Return on Assets: | 6.26% |
DaVita, Inc. Earnings Forecast
Key DaVita, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for DVA is 27.26%.
-
The Selling, General & Administrative Expenses for DVA have been equal to 12.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 32.96% of Operating Income.
-
The Net Earning history of DVA is 9.76% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 20 years.
DaVita, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | DVA |
| CUSIP: | 23918K |
| Website: | davita.com |
Debt
| Debt-to-Equity Ratio: | -22.34 |
|---|---|
| Current Ratio: | 1.36 |
| Quick Ratio: | 1.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.69 |
|---|---|
| Forward P/E Ratio: | 9.01 |
DVA Technical Analysis vs Fundamental Analysis
Buy
51
DaVita, Inc. (DVA)
is a Buy
Is DaVita, Inc. a Buy or a Sell?
-
DaVita, Inc. stock is rated a BuyThe current DaVita, Inc. [DVA] share price is $114.72. The Score for DVA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.